CKH Food & Health Limited
CXI Healthcare Technology Group Limited engages in the manufacture and distribution of health foods. It provides Chinese medicine-based health supplements in capsule, tablet, drink, and tea forms. The company was formerly known as CKH Food & Health Limited and changed its name to CXI Healthcare Technology Group Limited in October 2023. CXI Healthcare Technology Group Limited was founded in 2009 a… Read more
CKH Food & Health Limited (900120) - Net Assets
Latest net assets as of March 2025: ₩2.55 Billion KRW
Based on the latest financial reports, CKH Food & Health Limited (900120) has net assets worth ₩2.55 Billion KRW as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩2.56 Billion) and total liabilities (₩10.04 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩2.55 Billion |
| % of Total Assets | 99.61% |
| Annual Growth Rate | 75.83% |
| 5-Year Change | 22996.47% |
| 10-Year Change | -10.41% |
| Growth Volatility | 15140.33 |
CKH Food & Health Limited - Net Assets Trend (2007–2024)
This chart illustrates how CKH Food & Health Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CKH Food & Health Limited (2007–2024)
The table below shows the annual net assets of CKH Food & Health Limited from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | ₩481.14 Billion | +21012.05% |
| 2023-06-30 | ₩2.28 Billion | +4.84% |
| 2022-06-30 | ₩2.17 Billion | +2.14% |
| 2021-06-30 | ₩2.13 Billion | +2.16% |
| 2020-06-30 | ₩2.08 Billion | -21.76% |
| 2019-06-30 | ₩2.66 Billion | -13.83% |
| 2018-06-30 | ₩3.09 Billion | -12.02% |
| 2017-06-30 | ₩3.51 Billion | +0.64% |
| 2016-06-30 | ₩3.49 Billion | -99.35% |
| 2015-06-30 | ₩537.02 Billion | +29.39% |
| 2014-06-30 | ₩415.05 Billion | +6.33% |
| 2013-06-30 | ₩390.34 Billion | +22.08% |
| 2012-06-30 | ₩319.73 Billion | +43.02% |
| 2011-06-30 | ₩223.57 Billion | +22.00% |
| 2010-06-30 | ₩183.26 Billion | +62179.18% |
| 2009-06-30 | ₩294.25 Million | +157.23% |
| 2008-06-30 | ₩114.39 Million | +249.37% |
| 2007-06-30 | ₩32.74 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CKH Food & Health Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2393794.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩268.36 Billion | 55.78% |
| Other Components | ₩212.78 Billion | 44.22% |
| Total Equity | ₩481.14 Billion | 100.00% |
CKH Food & Health Limited Competitors by Market Cap
The table below lists competitors of CKH Food & Health Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Randgold & Exploration Company Limited
PINK:RNDXF
|
$590.99K |
|
Horisont Energi AS
OL:HRGI
|
$591.13K |
|
Monarca Minerals Inc
PINK:ORAGF
|
$591.26K |
|
Bravo Multinational Inc
PINK:BRVO
|
$591.36K |
|
K2 Capital Acquisition Corporation Rights
NASDAQ:KTWOR
|
$590.84K |
|
Secure Blockchain Development Corp.
F:8ID0
|
$590.10K |
|
METLIFE (MWZ.SG)
STU:MWZ
|
$590.08K |
|
Gaucho Group Holdings Inc
NASDAQ:VINO
|
$590.07K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CKH Food & Health Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,278,967,320 to 481,136,634,000, a change of 478,857,666,680 (21012.0%).
- Net income of 159,357,680 contributed positively to equity growth.
- Other factors increased equity by 478,698,309,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩159.36 Million | +0.03% |
| Other Changes | ₩478.70 Billion | +99.49% |
| Total Change | ₩- | 21012.05% |
Book Value vs Market Value Analysis
This analysis compares CKH Food & Health Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 12.72x to 0.02x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-06-30 | ₩31.61 | ₩402.00 | x |
| 2017-06-30 | ₩31.81 | ₩402.00 | x |
| 2018-06-30 | ₩27.99 | ₩402.00 | x |
| 2019-06-30 | ₩24.12 | ₩402.00 | x |
| 2020-06-30 | ₩18.87 | ₩402.00 | x |
| 2021-06-30 | ₩18.23 | ₩402.00 | x |
| 2022-06-30 | ₩17.67 | ₩402.00 | x |
| 2023-06-30 | ₩13.22 | ₩402.00 | x |
| 2024-06-30 | ₩16692.68 | ₩402.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CKH Food & Health Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.03%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 42.28%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.01x
- Recent ROE (0.03%) is below the historical average (4.66%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 24.02% | 33.88% | 0.61x | 1.15x | ₩25.69 Billion |
| 2011 | 25.00% | 29.58% | 0.75x | 1.13x | ₩33.53 Billion |
| 2012 | 21.23% | 28.68% | 0.58x | 1.28x | ₩35.90 Billion |
| 2013 | 15.50% | 22.86% | 0.55x | 1.24x | ₩21.47 Billion |
| 2014 | 15.33% | 22.21% | 0.59x | 1.17x | ₩22.11 Billion |
| 2015 | 13.68% | 23.11% | 0.51x | 1.17x | ₩19.75 Billion |
| 2016 | 8.28% | 17.61% | 0.45x | 1.04x | ₩-60.09 Million |
| 2017 | 0.13% | 0.54% | 0.24x | 1.03x | ₩-346.48 Million |
| 2018 | -14.18% | -50.90% | 0.26x | 1.07x | ₩-747.17 Million |
| 2019 | -15.96% | -54.61% | 0.28x | 1.05x | ₩-691.07 Million |
| 2020 | -27.81% | -155.25% | 0.17x | 1.02x | ₩-787.56 Million |
| 2021 | 1.40% | 4.87% | 0.28x | 1.03x | ₩-183.10 Million |
| 2022 | 1.48% | 5.90% | 0.25x | 1.02x | ₩-185.22 Million |
| 2023 | 1.74% | 10.51% | 0.16x | 1.01x | ₩-188.27 Million |
| 2024 | 0.03% | 42.28% | 0.00x | 1.01x | ₩-47.95 Billion |
Industry Comparison
This section compares CKH Food & Health Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $185,563,423,740
- Average return on equity (ROE) among peers: 1.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CKH Food & Health Limited (900120) | ₩2.55 Billion | 24.02% | 0.00x | $590.98K |
| Dongwha Pharm.Co.Ltd (000020) | $229.73 Billion | 2.15% | 0.36x | $75.32 Million |
| Yuhan Corp. (000100) | $323.58 Billion | 10.19% | 0.72x | $4.21 Billion |
| Yuyu Pharma Inc (000227) | $128.69 Billion | -1.72% | 0.50x | $26.44 Million |
| Ildong Holdings Co Ltd (000230) | $66.98 Billion | 10.88% | 1.80x | $49.55 Million |
| Samil Pharm (000520) | $62.87 Billion | 0.00% | 0.77x | $110.58 Million |
| Donga Socio Holdings (000640) | $328.69 Billion | 10.58% | 1.17x | $206.35 Million |
| Jw Pharmac (001060) | $223.83 Billion | 0.28% | 1.65x | $278.34 Million |
| JW Pharmaceutical Corp (001067) | $265.44 Billion | 13.94% | 1.43x | $489.75 Million |
| Samsung Pharm (001360) | $77.58 Billion | -31.98% | 0.20x | $65.82 Million |
| Ahn-Gook Pharmaceutical Co. Ltd (001540) | $148.25 Billion | 1.71% | 0.47x | $27.39 Million |